Fatty Acid Molecule Erucamide Halts Retinal Degeneration in Mice
A naturally occurring fatty acid amide activates immune cells in the retina, protecting neurons and blood vessels from degenerative damage.
20 articles
A naturally occurring fatty acid amide activates immune cells in the retina, protecting neurons and blood vessels from degenerative damage.
A phase 2/3 trial of the BACE inhibitor atabecestat in amyloid-positive asymptomatic adults was terminated before completion, raising questions about this drug class.
A traditional Chinese herbal formula improves cognition and cerebrovascular health in Alzheimer's mice by activating the LKB1-AMPK-SIRT1 autophagy cascade.
Phase 1b trial tests escalating doses of experimental Alzheimer's treatment BMS-984923 for safety and tolerability in older adults.
Dopamine agonist pramipexole significantly reduced depression symptoms when added to standard antidepressants in resistant cases.
A completed Phase 4 trial from India evaluates whether ALA supplementation boosts flunarizine's migraine-prevention power in adolescents.
Probucol, a discontinued cholesterol medication, may boost brain-protective proteins in older adults at risk for dementia.
A Phase 1/2 trial tests whether dexmedetomidine can enhance the brain's glymphatic system to clear amyloid and tau during sleep.
A Phase 2 trial investigates whether thiethylperazine, a decades-old antiemetic, can flush toxic amyloid beta from the brains of early AD patients.
Emerging mycotoxin found in foods crosses blood-brain barrier, disrupts neurotransmitters and impairs cognitive function in animal model.
DPCPX treatment enhanced neurogenesis and improved motor/memory function in stroke recovery studies using advanced PET imaging.
A Cochrane meta-analysis of 17 RCTs finds amyloid-targeting antibodies offer minimal cognitive gains while significantly raising ARIA risk.
Researchers built a machine learning imaging pipeline to detect cerebral microhemorrhages and tested SS-31 (elamipretide) in aged hypertensive mice.
Scientists develop pathway-selective drug that activates beneficial brain receptors while avoiding negative feedback loops.
Radix Bupleuri restores liver health by fixing bile acid balance and activating key metabolic pathways in animal studies.
A 5-year cohort study finds elevated blood palmitoleic acid โ a marker of excess energy intake โ accelerates brain hypometabolism linked to cognitive decline.
UC Davis scientists created novel brain-healing molecules that activate key serotonin receptors tied to neuroplasticity โ without triggering hallucinations.
A completed Phase 1 trial compared the abuse liability of rapastinel versus ketamine in recreational polydrug users, with implications for safer depression treatment.
A selective D3 receptor ligand reduces leg movement symptoms and improves sleep quality in a rat model of restless legs syndrome.
Researchers discover a phospholipid derivative that protects brain cells by calming overactive immune cells in dementia-prone mice.